Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 Diabetes
Clinical trial NCT00283751 · COMPLETED
Trial details
- NCT number
- NCT00283751
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
- Primary completion
- 2004-11-01
- Enrollment
- 583
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.